•
Dec 30, 2021

National CineMedia Q4 2021 Earnings Report

National CineMedia's Q4 2021 earnings showed a significant revenue increase and a return to profitability, marking progress in recovery from the pandemic's impact.

Key Takeaways

National CineMedia reported a strong recovery in Q4 2021, with a 304.5% increase in revenue to $63.5 million and a net income of $8.6 million, or $0.11 per diluted share, compared to a net loss in the same quarter of the previous year. The company's performance reflects the reopening of theaters and an increase in attendance, leading to positive Adjusted OIBDA for the first time since Q1 2020.

Total revenue increased by 304.5% to $63.5 million compared to the same quarter last year.

Operating income was $8.0 million, a 138.5% increase from an operating loss in Q4 2020.

Net income reached $8.6 million, or $0.11 per diluted share, a significant improvement from a net loss in Q4 2020.

Adjusted OIBDA turned positive at $18.4 million, marking the first positive figure since Q1 2020.

Total Revenue
$63.5M
Previous year: $15.7M
+304.5%
EPS
-$0.5
Previous year: -$6.2
-91.9%
Adjusted OIBDA
$18.4M
Total Attendance
112.1M
Previous year: 12.4M
+804.0%
Gross Profit
$55M
Previous year: $13.8M
+298.6%
Cash and Equivalents
$103M
Previous year: $182M
-43.6%
Total Assets
$817M
Previous year: $886M
-7.8%

National CineMedia

National CineMedia

National CineMedia Revenue by Segment

Forward Guidance

Due to uncertainties related to the COVID-19 pandemic, the Company is providing revenue and Adjusted OIBDA guidance for the first quarter of 2022 only. The Company expects to earn revenue of $32.0 to $35.0 million and Adjusted OIBDA of negative $7.0 million to negative $4.0 million for the first quarter of 2022.

Positive Outlook

  • Meaningful upfront bookings
  • Very strong high-quality film slate for the year
  • Growing consumer demand to return to the theaters
  • COVID-19 infection levels decrease
  • Mask mandates loosen

Challenges Ahead

  • Continued uncertainties related to the COVID-19 pandemic over the near term
  • Impact of changes in consumer behavior on attendance following the reopening of the theaters
  • Revenue of $32.0 to $35.0 million expected for Q1 2022
  • Adjusted OIBDA of negative $7.0 million to negative $4.0 million expected for Q1 2022
  • Inability to predict the amount and timing of impacts outside of the Company’s control, such as the ongoing COVID-19 pandemic